Close

Martin Meltzer

Lead

Education

Affiliations

Projects

Papers

Venkatesan S, Carias C, Biggerstaff M, Campbell AP, Nguyen-Van-Tam JS, Kahn E, Myles PR, Meltzer MI. (2019). Antiviral treatment for outpatient use during an influenza pandemic: a decision tree model of outcomes averted and cost-effectiveness. Journal of public health (Oxford, England), 41(2)

Bambery Z, Cassell CH, Bunnell RE, Roy K, Ahmed Z, Payne RL, Meltzer MI. (2018). Impact of a Hypothetical Infectious Disease Outbreak on US Exports and Export-Based Jobs. Health security, 16(1)

Adhikari BB, Koonin LM, Mugambi ML, Sliger KD, Washington ML, Kahn EB, Meltzer MI. (2018). Estimating Weekly Call Volume to a National Nurse Telephone Triage Line in an Influenza Pandemic. Health security, 16(5)

Skelton AG, Meltzer MI. (2017). 20 Years of Public Health Economics and Decision Sciences at the US Centers for Disease Control and Prevention: The CDC Steven M. Teutsch Prevention Effectiveness Fellowship, 1995-2015. Journal of public health management and practice : JPHMP, 23(4)

Fischer LS, Santibanez S, Hatchett RJ, Jernigan DB, Meyers LA, Thorpe PG, Meltzer MI. (2016). CDC Grand Rounds: Modeling and Public Health Decision-Making. MMWR. Morbidity and mortality weekly report, 65(48)

Meltzer MI, Santibanez S, Fischer LS, Merlin TL, Adhikari BB, Atkins CY, Campbell C, Fung IC, Gambhir M, Gift T, Greening B, Gu W, Jacobson EU, Kahn EB, Carias C, Nerlander L, Rainisch G, Shankar M, Wong K, Washington ML. (2016). Modeling in Real Time During the Ebola Response. MMWR supplements, 65(3)

Atkins CY, Thomas TK, Lenaker D, Day GM, Hennessy TW, Meltzer MI. (2016). Cost-effectiveness of preventing dental caries and full mouth dental reconstructions among Alaska Native children in the Yukon-Kuskokwim delta region of Alaska. Journal of public health dentistry, 76(3)

Adhikari BB, Goodson JL, Chu SY, Rota PA, Meltzer MI. (2016). Assessing the Potential Cost-Effectiveness of Microneedle Patches in Childhood Measles Vaccination Programs: The Case for Further Research and Development. Drugs in R&D, 16(4)

Meltzer MI, Gambhir M, Atkins CY, Swerdlow DL. (2015). Standardizing scenarios to assess the need to respond to an influenza pandemic. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Rainisch G, Shankar M, Wellman M, Merlin T, Meltzer MI. (2015). Regional spread of Ebola virus, West Africa, 2014. Emerging infectious diseases, 21(3)

Fung IC, Gambhir M, Glasser JW, Gao H, Washington ML, Uzicanin A, Meltzer MI. (2015). Modeling the effect of school closures in a pandemic scenario: exploring two different contact matrices. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

O'Hagan JJ, Wong KK, Campbell AP, Patel A, Swerdlow DL, Fry AM, Koonin LM, Meltzer MI. (2015). Estimating the United States demand for influenza antivirals and the effect on severe influenza disease during a potential pandemic. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Rainisch G, Asher J, George D, Clay M, Smith TL, Kosmos C, Shankar M, Washington ML, Gambhir M, Atkins C, Hatchett R, Lant T, Meltzer MI. (2015). Estimating Ebola Treatment Needs, United States. Emerging infectious diseases, 21(7)

Meltzer MI, Patel A, Ajao A, Nystrom SV, Koonin LM. (2015). Estimates of the demand for mechanical ventilation in the United States during an influenza pandemic. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Ajao A, Nystrom SV, Koonin LM, Patel A, Howell DR, Baccam P, Lant T, Malatino E, Chamberlin M, Meltzer MI. (2015). Assessing the Capacity of the US Health Care System to Use Additional Mechanical Ventilators During a Large-Scale Public Health Emergency. Disaster medicine and public health preparedness, 9(6)

Zhou L, Situ S, Feng Z, Atkins CY, Fung IC, Xu Z, Huang T, Hu S, Wang X, Meltzer MI. (2014). Cost-effectiveness of alternative strategies for annual influenza vaccination among children aged 6 months to 14 years in four provinces in China. PLoS One, 9(1)

Meltzer MI, Atkins CY, Santibanez S, Knust B, Petersen BW, Ervin ED, Nichol ST, Damon IK, Washington ML, . (2014). Estimating the future number of cases in the Ebola epidemic--Liberia and Sierra Leone, 2014-2015. MMWR supplements, 63(3)

Borse RH, Singleton RJ, Bruden DT, Fry AM, Hennessy TW, Meltzer MI. (2014). The Economics of Strategies to Reduce Respiratory Syncytial Virus Hospitalizations in Alaska. Journal of the Pediatric Infectious Diseases Society, 3(3)

Borse RH, Shrestha SS, Fiore AE, Atkins CY, Singleton JA, Furlow C, Meltzer MI. (2013). Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009-2010. Emerging infectious diseases, 19(3)

Shrestha SS, Sosin DM, Meltzer MI. (2012). Planning for baseline medical care needs of a displaced population after a disaster. Disaster medicine and public health preparedness, 6(4)

Prosser LA, Lavelle TA, Fiore AE, Bridges CB, Reed C, Jain S, Dunham KM, Meltzer MI. (2011). Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States. PLoS One, 6(7)

Shrestha SS, Swerdlow DL, Borse RH, Prabhu VS, Finelli L, Atkins CY, Owusu-Edusei K, Bell B, Mead PS, Biggerstaff M, Brammer L, Davidson H, Jernigan D, Jhung MA, Kamimoto LA, Merlin TL, Nowell M, Redd SC, Reed C, Schuchat A, Meltzer MI. (2011). Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Atkins CY, Patel A, Taylor TH Jr., Biggerstaff M, Merlin TL, Dulin SM, Erickson BA, Borse RH, Hunkler R, Meltzer MI. (2011). Estimating effect of antiviral drug use during pandemic (H1N1) 2009 outbreak, United States. Emerging infectious diseases, 17(9)

Borse RH, Behravesh CB, Dumanovsky T, Zucker JR, Swerdlow D, Edelson P, Choe-Castillo J, Meltzer MI. (2011). Closing schools in response to the 2009 pandemic influenza A H1N1 virus in New York City: economic impact on households. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Shrestha SS, Wallace GS, Meltzer MI. (2010). Modeling the national pediatric vaccine stockpile: supply shortages, health impacts and cost consequences. Vaccine, 28(38)

Somda ZC, Perry HN, Messonnier NR, Djingarey MH, Ki SO, Meltzer MI. (2010). Modeling the cost-effectiveness of the integrated disease surveillance and response (IDSR) system: meningitis in Burkina Faso. PLoS One, 5(9)

Meltzer MI, McNeill KM, Miller JD. (2010). Laboratory surge capacity and pandemic influenza. Emerging infectious diseases, 16(1)

Meltzer MI. (2008). Health economics and prioritising health care. Lancet (London, England), 372(9639)

Dhankhar P, Vaidya SA, Fishbien DB, Meltzer MI. (2008). Cost effectiveness of rabies post exposure prophylaxis in the United States. Vaccine, 26(33)

Meltzer MI. (2008). Pandemic influenza, reopening schools, and returning to work. Emerging infectious diseases, 14(3)

Meltzer MI. (2008). Increased hospitalizations of elderly patients. Emerging infectious diseases, 14(5)

Meltzer MI, Neuzil KM, Griffin MR, Fukuda K. (2005). An economic analysis of annual influenza vaccination of children. Vaccine, 23(8)

Kaufmann AF, Pesik NT, Meltzer MI. (2005). Syndromic surveillance in bioterrorist attacks. Emerging infectious diseases, 11(9)

Roy K, Wang SA, Meltzer MI. (2005). Optimizing treatment of antimicrobial-resistant Neisseria gonorrhoeae. Emerging infectious diseases, 11(8)

Washington ML, Mason J, Meltzer MI. (2005). Maxi-Vac: planning mass smallpox vaccination clinics. Journal of public health management and practice : JPHMP, 11(6)

Shepard DS, Suaya JA, Halstead SB, Nathan MB, Gubler DJ, Mahoney RT, Wang DN, Meltzer MI. (2004). Cost-effectiveness of a pediatric dengue vaccine. Vaccine, 22(9-10)

Meltzer MI. (2004). Multiple contact dates and SARS incubation periods. Emerging infectious diseases, 10(2)

Scott RD 2nd., Gregg E, Meltzer MI. (2004). Collecting data to assess SARS interventions. Emerging infectious diseases, 10(7)

Meltzer MI, Terlouw DJ, Kolczak MS, Odhacha A, ter Kuile FO, Vulule JM, Alaii JA, Nahlen BL, Hawley WA, Phillips-Howard PA. (2003). The household-level economics of using permethrin-treated bed nets to prevent malaria in children less than five years of age. The American journal of tropical medicine and hygiene, 68(4 Suppl)

Meltzer MI. (2003). Risks and benefits of preexposure and postexposure smallpox vaccination. Emerging infectious diseases, 9(11)

Meltzer MI, Bridges CB. (2003). Economic analysis of influenza vaccination and treatment. Annals of internal medicine, 138(7)